Pink Sheet
>>Compliance

US FDA ‘Brainstorms’ For Ways To Resume Pre-Pandemic Inspection Cadence

10 Mar 2023

The FDA's drug inspections director discusses trends and challenges in remarks at a Georgia GMP conference, while declining to share specific ideas generated in last week’s agency brainstorming session.

Brainstorming session — Getting together to get back on track after the pandemic • Source: Shutterstock

US Food and Drug Administration staff met in early March to brainstorm ways to catch up on inspections in the wake of the COVID-19 pandemic, the official who oversees drug inspections told the International GMP Conference in Athens, GA.

Inspection activity dropped significantly in March 2020 after the agency suspended most travel due to the spread of the coronavirus